Role of TLRs in Brucella mediated murine DC activation in vitro and clearance of pulmonary infection in vivo

Vaccine

Volumn 30, Issue 8, 2012, Pages 1502-1512

  Surendran, Naveen ^a,e   Hiltbold, Elizabeth M ^b   Heid, Bettina ^a   Akira, Shizuo ^c   Standiford, Theodore J ^d   Sriranganathan, Nammalwar ^a   Boyle, Stephen M ^a   Zimmerman, Kurt L ^a   Makris, Melissa R ^a   Witonsky, Sharon G ^a  

^a CENTER FOR MOLECULAR MEDICINE AND INFECTIOUS DISEASES   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c OSAKA UNIVERSITY   (Japan)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Aerosol infection; Brucella; Dendritic cells; Strain 2308; Strain RB51; Toll Like Receptors

Indexed keywords

BRUCELLA VACCINE; CD40 ANTIGEN; CD86 ANTIGEN; GLYCOPROTEIN P 15095; INTERLEUKIN 12; INTERLEUKIN 12P70; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RB 51; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 2 AGONIST; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 4 AGONIST; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL STRAIN; BONE MARROW CELL; BONE MARROW DERIVED DENDRITIC CELL; BRUCELLA ABORTUS; BRUCELLOSIS; CELL ACTIVATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG SCREENING; FEMALE; KNOCKOUT MOUSE; LUNG INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION;

ANIMALS; BRONCHOPNEUMONIA; BRUCELLA ABORTUS; BRUCELLOSIS; CELLS, CULTURED; DENDRITIC CELLS; FEMALE; LUNG; MICE; MICE, INBRED BALB C; TOLL-LIKE RECEPTORS;

EID: 84856574277     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.12.036     Document Type: Article

References (34)

1. Zoonoses and communicable diseases common to man and animal 2001, Pan American Health Organization, WHO. P. Acha, B. Szyfres (Eds.).
2. Pappas G., Panagopoulou P., Christou L., Akritidis N. Brucella as a biological weapon. Cell Mol Life Sci 2006 Oct, 63(19-20):2229-2236.
3. Genome Mapping and Genomics in Animal-Associated Microbes 2009, Springer-Verlag, Berlin, Heidelberg. 1st ed. V. Nene, Kole, Chittaranjan (Eds.).
4. Brucellosis in humans and animals 2006, World Health Organization. M.J. Corbel (Ed.).
5. Schurig G.G., Roop R.M., Bagchi T., Boyle S., Buhrman D., Sriranganathan N. Biological properties of RB51; a stable rough strain of Brucella abortus. Vet Microbiol 1991 Jul, 28(2):171-188.
6. He Y., Vemulapalli R., Zeytun A., Schurig G.G. Induction of specific cytotoxic lymphocytes in mice vaccinated with Brucella abortus RB51. Infect Immun 2001 Sep, 69(9):5502-5508.
7. Veterinary immunology: an introduction 2008, Elsevier. 8th ed. I.R. Tizard (Ed.).
8. Barquero-Calvo E., Chaves-Olarte E., Weiss D.S., Guzman-Verri C., Chacon-Diaz C., Rucavado A., et al. Brucella abortus uses a stealthy strategy to avoid activation of the innate immune system during the onset of infection. PLoS ONE 2007, 2(7):e631.
9. Huang L.Y., Reis e Sousa C., Itoh Y., Inman J., Scott D.E. IL-12 induction by a TH1-inducing adjuvant in vivo: dendritic cell subsets and regulation by IL-10. J Immunol 2001 August, 167(3):1423-1430.
10. Billard E., Cazevieille C., Dornand J., Gross A. High susceptibility of human dendritic cells to invasion by the intracellular pathogens Brucella suis, B. abortus, and B. melitensis. Infect Immun 2005 Dec, 73(12):8418-8424.
11. Janeway C.A., Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002, 20:197-216.
12. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998 March, 392(6673):245-252.
13. Weiss D.S., Takeda K., Akira S., Zychlinsky A., Moreno E. MyD88, but not toll-like receptors 4 and 2, is required for efficient clearance of Brucella abortus. Infect Immun 2005 Aug, 73(8):5137-5143.
14. Oliveira S.C., de Oliveira F.S., Macedo G.C., de Almeida L.A., Carvalho N.B. The role of innate immune receptors in the control of Brucella abortus infection: toll-like receptors and beyond. Microbes Infect 2008 Jul, 10(9):1005-1009.
15. Huang L.Y., Ishii K.J., Akira S., Aliberti J., Golding B. Th1-like cytokine induction by heat-killed Brucella abortus is dependent on triggering of TLR9. J Immunol 2005 September, 175(6):3964-3970.
16. Zwerdling A., Delpino M.V., Barrionuevo P., Cassataro J., Pasquevich K.A., Garcia Samartino C., et al. Brucella lipoproteins mimic dendritic cell maturation induced by Brucella abortus. Microbes Infect 2008 October, 10(12-13):1346-1354.
17. Copin R., De Baetselier P., Carlier Y., Letesson J.J., Muraille E. MyD88-dependent activation of B220-CD11b+LY-6C+ dendritic cells during Brucella melitensis infection. J Immunol 2007 April, 178(8):5182-5191.
18. Macedo G.C., Magnani D.M., Carvalho N.B., Bruna-Romero O., Gazzinelli R.T., Oliveira S.C. Central role of MyD88-dependent dendritic cell maturation and proinflammatory cytokine production to control Brucella abortus infection. J Immunol 2008 January, 180(2):1080-1087.
19. Neutra M.R., Kozlowski P.A. Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 2006 February, 6(2):148-158.
20. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992 December, 176(6):1693-1702.
21. Surendran N., Hiltbold E.M., Heid B., Sriranganathan N., Boyle S.M., Zimmerman K.L., et al. Heat-killed and gamma-irradiated Brucella strain RB51 stimulates enhanced dendritic cell activation, but not function compared with the virulent smooth strain 2308. FEMS Immunol Med Microbiol 2010 Nov, 60(2):147-155.
22. Billard E., Dornand J., Gross A. Brucella suis prevents human dendritic cell maturation and antigen presentation through regulation of tumor necrosis factor alpha secretion. Infect Immun 2007 October, 75(10):4980-4989.
23. Vemulapalli R., He Y., Cravero S., Sriranganathan N., Boyle S.M., Schurig G.G. Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51. Infect Immun 2000 June, 68(6):3286-3289.
24. Surendran N., Hiltbold E.M., Heid B., Sriranganathan N., Boyle S.M., Zimmerman K.L., et al. Live Brucella abortus rough vaccine strain RB51 stimulates enhanced innate immune response in vitro compared to rough vaccine strain RB51SOD and virulent smooth strain 2308 in murine bone marrow-derived dendritic cells. Vet Microbiol 2010 June.
25. Campos M.A., Rosinha G.M., Almeida I.C., Salgueiro X.S., Jarvis B.W., Splitter G.A., et al. Role of Toll-like receptor 4 in induction of cell-mediated immunity and resistance to Brucella abortus infection in mice. Infect Immun 2004 Jan, 72(1):176-186.
26. Forestier C., Deleuil F., Lapaque N., Moreno E., Gorvel J.P. Brucella abortus lipopolysaccharide in murine peritoneal macrophages acts as a down-regulator of T cell activation. J Immunol 2000 November, 165(9):5202-5210.
27. Billard E., Dornand J., Gross A. Interaction of Brucella suis and Brucella abortus rough strains with human dendritic cells. Infect Immun 2007 December, 75(12):5916-5923.
28. Huang L.Y., Aliberti J., Leifer C.A., Segal D.M., Sher A., Golenbock D.T., et al. Heat-killed Brucella abortus induces TNF and IL-12p40 by distinct MyD88-dependent pathways: TNF, unlike IL-12p40 secretion, is Toll-like receptor 2 dependent. J Immunol 2003 August, 171(3):1441-1446.
29. Krummen M., Balkow S., Shen L., Heinz S., Loquai C., Probst H.C., et al. Release of IL-12 by dendritic cells activated by TLR ligation is dependent on MyD88 signaling, whereas TRIF signaling is indispensable for TLR synergy. J Leukoc Biol 2010, 88:189-199.
30. O'Neill L.A. How Toll-like receptors signal: what we know and what we don't know. Curr Opin Immunol 2006 Feb, 18(1):3-9.
31. Archer K.A., Roy C.R. MyD88-dependent responses involving toll-like receptor 2 are important for protection and clearance of Legionella pneumophila in a mouse model of Legionnaires' disease. Infect Immun 2006 June, 74(6):3325-3333.
32. Malik M., Bakshi C.S., Sahay B., Shah A., Lotz S.A., Sellati T.J. Toll-like receptor 2 is required for control of pulmonary infection with Francisella tularensis. Infect Immun 2006 June, 74(6):3657-3662.
33. Surendran N., Zimmerman K., Seleem M.N., Sriranganathan N., Boyle S.M., Hiltbold E.M., et al. Ability of Brucella abortus rough vaccine strains to elicit DC and innate immunity in lung using a murine respiratory model. Vaccine 2010 October, 28(43):7009-7015.
34. Surendran N., Sriranganathan N., Lawler H., Boyle S.M., Hiltbold E.M., Heid B., et al. Efficacy of vaccination strategies against intranasal challenge with Brucella abortus in BALB/c mice. Vaccine 2011 February.